Trials / Completed
CompletedNCT00145132
Beta-CIT-SPECT and Neurophysiology in Depression
Serotonin and Dopamine Transporter (SERT, DAT) Availabilities as Assessed by b-CIT and SPECT, and Neurophysiological Measures of Central Serotonergic Activity in Patients With Depression Under Treatment With Escitalopram
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Ludwig-Maximilians - University of Munich · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Aim of this project is to investigate the effects of escitalopram on monoamine transporter (SERT, DAT) availabilities as assessed by b-CIT and SPECT, and on neurophysiological parameters such as the loudness dependence of auditory evoked potentials (LDAEP) in patients with depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | β-CIT-SPECT, Neurophysiology | β-CIT-SPECT scans and EEG recordings, two assessments each |
Timeline
- Start date
- 2005-06-01
- Primary completion
- 2009-12-01
- Completion
- 2009-12-01
- First posted
- 2005-09-05
- Last updated
- 2010-06-02
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00145132. Inclusion in this directory is not an endorsement.